Monitoring long-term parenteral nutrition

被引:10
作者
Dibb, Martyn [1 ]
Lal, Simon [2 ]
机构
[1] Royal Liverpool Univ Hosp, Prescot St, Liverpool L78XP, Merseyside, England
[2] Salford Royal Hosp, Salford, Lancs, England
关键词
home parenteral nutrition; intestinal failure; metabolic bone disease; CHRONIC INTESTINAL FAILURE; ADULT PATIENTS; PREVALENCE; CARE; OSTEOPOROSIS; INDICATORS; GUIDELINES; DISEASE; RISK;
D O I
10.1097/MOG.0000000000000504
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review This review discusses the monitoring aimed at achieving good long-term outcomes in people dependent on home parenteral nutrition (HPN). Recent findings There have been recent studies highlighting the importance of treating low bone mineral density in HPN-dependent patients, methods of screening for liver disease, assessment of quality of life (QoL) and the need for early assessment for intestinal transplantation and growth factor therapy. Summary High-quality HPN services require expert multidisciplinary teams with a focus on strict aseptic catheter care protocols alongside regular monitoring and management of clinical, laboratory and patient-related factors. Areas that should be considered in the routine monitoring of HPN include regular laboratory measurements, QoL, assessment for intestinal failure-associated liver disease, treatment of metabolic bone disease and consideration of evolving treatments, alongside management of any underlying condition leading to intestinal failure.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 46 条
[1]   Intestinal transplantation and the European implication: impact of experience and study design [J].
Abu-Elmagd, Kareem M. ;
Mazariegos, George .
GUT, 2012, 61 (01) :166-166
[2]  
Baruch D, 2018, CUTIS, V101, P450
[3]  
Baxter JP, 2018, CLIN NUTR
[4]   Organization of managed clinical networking for home parenteral nutrition [J].
Baxter, JR ;
Mckee, RF .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2006, 9 (03) :270-275
[5]  
Biesalski HK., 2009, GER MED SCI, V7, P21
[6]   Hyperkalemia secondary to concurrent pharmacotherapy in a patient receiving home parenteral nutrition [J].
Brown, RO ;
Hamrick, KD ;
Dickerson, RN ;
Lee, N ;
Parnell, DH ;
Kudsk, KA .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1996, 20 (06) :429-432
[7]   The impact of home parenteral nutrition on the burden of disease including morbidity, mortality and rate of hospitalisations [J].
Burden, Sorrel ;
Hemstock, Matthew ;
Taylor, Michael ;
Teubner, Antje ;
Roskell, Neil ;
MacCulloch, Alasdair ;
Abraham, Arun ;
Lal, Simon .
CLINICAL NUTRITION ESPEN, 2018, 28 :222-227
[8]  
Burden ST, 2018, CLIN NUTR
[9]  
Canovai E, 2018, CLIN NUTR
[10]   Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure [J].
Cavicchi, M ;
Beau, P ;
Crenn, P ;
Degott, C ;
Messing, B .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (07) :525-532